Sign in

Geremy clair

@geremyclair.bsky.social
98 followers 255 following 8 posts

Biomedical Scientist using spatial omics to understand cellular and molecular interactions in pulmonary and kidney diseases.

PostsRepliesMedia
Geremy clair @geremyclair.bsky.social · 20/06/2025
🚀 Off the press! Deep generative AI and multi-omics datasets are revolutionizing drug screening. Check out the findings here: www.nature.com/articles/s41.... It was incredible to be part of this endeavor. Learn more about UNAGI here🐡 🐍: medicine.yale.edu/news-article... @kaminskimed.bsky.social
nature.com
A deep generative model for deciphering cellular dynamics and in silico drug discovery in complex diseases - Nature Biomedical Engineering
UNAGI deciphers cellular dynamics from human disease time-series single-cell data and facilitates in silico drug perturbations to discover drugs potentially active against complex human diseases.
021
Geremy clair @geremyclair.bsky.social · 06/12/2024
New publication 🫁 📊 🔬 ! We performed proteomics and transcriptomics of lung sorted cells from human (0 to 8 years). We discovered new cell markers and pathway modulated during development. A must-read for #teamMassSpec enthusiasts focused on development www.atsjournals.org/doi/abs/10.1...
atsjournals.org
Increased Pulmonary GM-CSF Causes Alveolar Macrophage Accumulation. Mechanistic Implications for Desquamative Interstitial Pneumonitis
012
Geremy clair @geremyclair.bsky.social · 03/12/2024
🚨 Exciting new research alert! We're thrilled to have contributed to this work that uncovers the role of EMC3 in managing the SFTPCI73T mutation linked to interstitial lung disease and the role of other genes such as EMC3 and VCP in surfactant trafficking www.jci.org/articles/vie... (a thread 1/4)
jci.org
JCI - EMC3 regulates trafficking and pulmonary toxicity of the SFTPCI73T mutation associated with interstitial lung disease
100